US drug approvals
11 approvals with a product on the US market
- Lomustine ANDA219265 · approved 27 Oct 2025
- Clindamycin Phosphate ANDA219612 · approved 13 Jun 2025
- Balsalazide Disodium ANDA219422 · approved 3 Apr 2025
- Primidone ANDA218366 · approved 23 Jan 2024
- Famotidine ANDA217137 · approved 7 Jul 2023
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.